Kuros Biosciences (KURN.SW, SIX) +5.58% to CHF28.40 23 Jan 2026: key catalysts ahead
Intraday: KURN.SW stock rises to CHF28.40 (+5.58%) on 23 Jan 2026; model projects CHF38.06 yearly
Intraday: KURN.SW stock rises to CHF28.40 (+5.58%) on 23 Jan 2026; model projects CHF38.06 yearly
Kaonavi (4435.T stock) at JPY 4,365 after an oversold bounce; Meyka AI grade, forecast and trade plan for JPX investors
The recent earnings report from Ixigo’s parent company, Le Travenues Technology, has shaken the market. Shares dropped as much as 16% soon after the results were released. This move startled many investors. It raised a key question: Is this drop a chance to buy the stock or a sign to cut losses? What the Q3…
Intraday update on DBPK.DE stock: price EUR 0.16, volume 35.63M on XETRA, rising volatility and mixed forecasts
S&P 500 (^GSPC) rises as Greenland security deal talks ease EU tariff risk. We unpack NATO Arctic security angles, Denmark Greenland sovereignty stances, and what this means for Japan markets.
XCF.SI stock closed S$0.044 on 23 Jan 2026; very oversold RSI suggests a short-term bounce opportunity
GIB-A.TO stock trades at **C$121.84** ahead of Q1 earnings Jan 28; watch margins and guidance
AQX.AX stock fell 26.67% to A$0.011 on 23 Jan 2026 with heavy volume. Meyka AI forecast and price targets inside.
Oriental Daily’s digital push across on.cc, epaper, mobile and video signals a shift in the Hong Kong advertising market. We explain the pricing, reach and investor angles.
BSSP stock sees a 3,000,000-share volume spike on 23 Jan 2026; analysis of liquidity, valuation and Meyka AI forecast for investors